研报掘金丨华泰证券:上调新和成至“买入”评级,上调目标价至38.24元
Ge Long Hui A P P·2026-01-06 07:53

Core Viewpoint - Huatai Securities report indicates that New Hope Liuhe is a leading global enterprise in nutrition and flavoring, with sales of methionine, vitamins, and PPS ranking among the top five globally, showcasing integrated, scaled, and technological advantages [1] Group 1: Company Overview - New Hope Liuhe is positioned in emerging demands for human and animal nutrition, flavoring, and specialty engineering materials, establishing a solid technological foundation [1] - The company is entering a new growth cycle, driven by the increasing global market share of methionine and flavoring products, as well as breakthroughs in biomanufacturing and new materials [1] Group 2: Market Analysis - The market has overly focused on the cyclical fluctuations of vitamins, neglecting the growth potential of methionine and flavoring products, as well as the company's global competitive advantages and the investment value of emerging business growth [1] Group 3: Financial Projections - The profit forecast for 2025-2027 has been slightly adjusted upwards, reflecting the continued growth in methionine and flavoring products, with the target price raised to 38.24 yuan, representing a 49% increase, and the rating upgraded to "Buy" [1]